Point Biopharma Global Stock Number Of Shares Shorted
PNTDelisted Stock | USD 9.06 0.10 1.09% |
POINT Biopharma Global fundamentals help investors to digest information that contributes to POINT Biopharma's financial success or failures. It also enables traders to predict the movement of POINT Stock. The fundamental analysis module provides a way to measure POINT Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to POINT Biopharma stock.
POINT |
POINT Biopharma Global Company Number Of Shares Shorted Analysis
POINT Biopharma's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current POINT Biopharma Number Of Shares Shorted | 2.64 M |
Most of POINT Biopharma's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, POINT Biopharma Global is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, POINT Biopharma Global has 2.64 M of outstending shares currently sold short by investors. This is 17.54% lower than that of the Biotechnology sector and 48.24% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 43.93% higher than that of the company.
POINT Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses POINT Biopharma's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of POINT Biopharma could also be used in its relative valuation, which is a method of valuing POINT Biopharma by comparing valuation metrics of similar companies.POINT Biopharma is currently under evaluation in number of shares shorted category among its peers.
POINT Fundamentals
Return On Equity | 0.26 | |||
Return On Asset | 0.17 | |||
Profit Margin | 0.40 % | |||
Operating Margin | (10.62) % | |||
Current Valuation | 1 B | |||
Shares Outstanding | 106.57 M | |||
Shares Owned By Insiders | 14.97 % | |||
Shares Owned By Institutions | 48.91 % | |||
Number Of Shares Shorted | 2.64 M | |||
Price To Book | 3.13 X | |||
Price To Sales | 5.45 X | |||
Revenue | 226.58 M | |||
EBITDA | 127.32 M | |||
Net Income | 98.29 M | |||
Cash And Equivalents | 199.43 M | |||
Cash Per Share | 2.21 X | |||
Total Debt | 3.56 M | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 10.90 X | |||
Book Value Per Share | 4.01 X | |||
Cash Flow From Operations | 183.52 M | |||
Short Ratio | 0.98 X | |||
Earnings Per Share | 1.10 X | |||
Target Price | 12.5 | |||
Number Of Employees | 129 | |||
Beta | -0.003 | |||
Market Capitalization | 1.33 B | |||
Total Asset | 578.32 M | |||
Retained Earnings | 39.01 M | |||
Working Capital | 451.08 M | |||
Net Asset | 578.32 M |
About POINT Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze POINT Biopharma Global's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of POINT Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of POINT Biopharma Global based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in POINT Stock
If you are still planning to invest in POINT Biopharma Global check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the POINT Biopharma's history and understand the potential risks before investing.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Money Managers Screen money managers from public funds and ETFs managed around the world |